Praxis Precision Medicines (PRAX) halted, news pending
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St futures rise as AI stocks catch their breath; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts PRAX Hot Sheet
Join SI Premium – FREE
Praxis Precision Medicines (PRAX) halted, news pending
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CRISPR Therapeutics names Siva Sakhamuri as chief technical officer
- Fluence Energy replaces CEO and CFO amid operational overhaul
- Standard Nuclear wins ~$7M ARPA-E grant to develop TRISO fuel from recycled material
Create E-mail Alert Related Categories
Corporate News, Trading HaltsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
